Phase 3 Study of Pemetrexed Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy.
Phase of Trial: Phase III
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Pemetrexed (Primary) ; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 06 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Apr 2010 Actual number of patients changed from 210 to 211 as reported by ClinicalTrials.gov record.
- 02 Apr 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History